ROCHE's HIVID APPROVED FOR MONOTHERAPY IN HIV-INFECTED PATIENTS; NEW INDICATIONS FOR COMBINATION THERAPY WITH RETROVIR COME UNDER ACCELERATED APPROVAL

Roche's Hivid is approved for second-line monotherapy in HIV- infected patients who experience disease progression with zidovudine treatment or who are intolerant to zidovudine. The new indication was approved Aug. 5.